Brief: LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients

Livanova

06/06/2024 14:08

June 6 (Reuters) - LivaNova PLC  LIVN.O :
    * LIVANOVA PROVIDES UPDATE ON RECOVER CLINICAL STUDY
EVALUATING
VNS THERAPY FOR TREATMENT-RESISTANT DEPRESSION IN UNIPOLAR
PATIENTS
    * LIVANOVA PLC: PRIMARY ENDPOINT DID NOT ACHIEVE STATISTICAL
SIGNIFICANCE IN UNIPOLAR PATIENT COHORT
    * LIVANOVA PLC: STATISTICALLY SIGNIFICANT AND CLINICALLY
MEANINGFUL BENEFITS SEEN IN SELECT SECONDARY ENDPOINTS; NO
SAFETY CONCERNS IDENTIFIED
    * LIVANOVA :  EXPECTS TO PUBLISH UNIPOLAR COHORT DATA
INCLUDING
DETAILS ON PE AND SECONDARY ENDPOINTS, IN PEER-REVIEWED JOURNALS
IN Q4 2024

Source text for Eikon:  ID:nBwb1wz8Ha 
Further company coverage:  LIVN.O 

 ((Reuters.Briefs@thomsonreuters.com;))